Form 4: Progyny Executive Trades PGNY Shares

Progyny Chief Product Officer Geoffrey Clapp executed a series of transactions involving Progyny, Inc. (PGNY) common stock on June 2, 2026.

Summary

• Geoffrey Clapp, Chief Product Officer at Progyny, Inc., engaged in several stock transactions on June 2, 2026.
• He disposed of 1,530 shares of common stock at a price of $25.58 per share.
• Clapp acquired 12,909 shares of common stock at a price of $20.91 per share.
• Additionally, 11,379 shares were disposed of under a transaction code 'F' at a price of $25.54 per share, noted as shares withheld for tax payments upon vesting of restricted stock units.
• Following these transactions, Clapp beneficially owns 72,026 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, reflecting standard executive compensation and tax-related stock disposals, with a modest acquisition that doesn't strongly signal a major shift in sentiment.

Positives

• Acquisition of 12,909 shares at a lower price ($20.91) suggests potential for future appreciation or a strategic purchase by management.
• The Chief Product Officer continues to hold a significant number of shares (72,026) directly, indicating continued confidence in the company.

Negatives

• Disposal of 1,530 shares at a higher price ($25.58) could indicate a partial divestment by management.
• The withholding of 11,379 shares for tax payments is a common occurrence upon vesting but represents a reduction in the number of shares received by the executive.

Risks

• The disposal of shares, even if for tax purposes, could be interpreted negatively by the market if not clearly understood as standard procedure.
• Vesting schedules for restricted stock units, as mentioned in the explanation, are subject to continued service, implying a risk of forfeiture if employment conditions are not met.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance. However, the vesting schedule for restricted stock units extends through March 17, 2028, implying a continued commitment from the reporting person over that period.

Management Comments

• Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
• 33% of the shares will vest on March 17, 2026, with the remainder vesting quarterly in equal installments thereafter through March 17, 2028, subject to the Reporting Person's continued service on each applicable vesting date.

Industry Context

StockSavvy.ai notes that executive stock transactions, particularly Form 4 filings, are closely watched by investors as they can provide insights into management's confidence in the company's future prospects. The specific details of acquisitions and disposals, along with the reasons cited (like tax withholding), are crucial for interpretation.

Stakeholder Impact

• Shareholders: May interpret the acquisition as a positive signal of management confidence, while disposals, even for tax reasons, could be viewed with caution.
• Employees: The vesting of restricted stock units impacts the compensation and potential wealth of the reporting person, aligning their interests with long-term company performance.
• Management: The transactions reflect the standard compensation and tax management practices for executives.

Next Steps

• Continued vesting of restricted stock units through March 17, 2028, contingent on continued service.
• Potential future stock transactions by the reporting person as vesting occurs or as personal financial needs dictate.

Key Dates

Keywords

Progyny, PGNY, Form 4, Stock Transaction, Beneficial Ownership, Executive Trading, Chief Product Officer, Restricted Stock Units, Securities Exchange Act